At present, restoring the viscoelasticity of the synovial fluid by intra-articular administration of HA, called viscosupplementation (VS), is the treatment of choice for OA patients. Compared with NSAIDs and corticosteroids, VS avoids the adverse events linked to these drugs, provides longer effects, treats not only pain but also stiffness and loss of motion, and protects cartilage.